Please assess the completion status of the following clinical trial:

Trial Title: PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cirrhosis of any aetiology~* Diuretic resistant ascites defined as i) an inability to mobilise ascites (minimal or no weight loss) despite administration with the maximum tolerable doses of oral diuretics or a daily dose of spironolactone 400 mg and re-accumulation of fluid after therapeutic paracentesis within two weeks or ii) diuretic-related complications including (but not limited to) azotemia, hepatic encephalopathy, or progressive electrolyte imbalances~* Able to read and understand Danish~* Signed and dated informed consent form~* Willing to comply with all study procedures and be available for the duration of the study~* Male or female of any age~* Age at least 18 years~* Expected survival at least three months.~Exclusion Criteria:~* Participants eligible and listed for TIPS~* Serum creatinine levels above 135 umol/L~* Overt hepatic encephalopathy in the two weeks before randomization~* Ascites due to other causes than cirrhosis such as: malignant disease, congestive heart failure, end-stage renal disease, pancreatitis, or Budd-Chiari (hepatic vein thrombosis), or chylous ascites~* Ongoing intra-abdominal infection (peritonitis) or active systemic or local infections, such as urinary tract infection or pneumonia~* Participation in a clinical study that may interfere with participation in this study;~* Evidence of extensive ascites loculation~* Coagulopathy~* Variceal bleeding within two weeks before randomisation~* Intraabdominal surgery within four months before randomisation~* Spontaneous bacterial peritonitis (neutrophil count\>250/µl within 24 hours of randomization)~* Patients with an increased risk of procedure related complications as judged by the primary healthcare provider

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PleurX (Type: EXPERIMENTAL): The PleurX catheter is a tunnelated peritoneal catheter, designed for permanent placement in the peritoneal cavity. The catheter is placed by a physician under sterile conditions. Drainage of ascites is done using vacuum bottles connected to the catheter. This can be managed by a home nurse or the patient.
- Large Volume Paracentesis (Type: ACTIVE_COMPARATOR): Large volume paracentesis is performed in sterile technique, a small incision is made through the skin, and a catheter is inserted through muscle and peritoneum. After the procedure, the patient remains in hospital for observation until the fluid is drained.

Based on this trial design, predict the completion outcome and termination type (if applicable).